All BrevisRefero Corporation for Chemistry, Manufacturing and Controls articles

  • Low-Res_Virus and antibodies close up, microorganism, a microscopic organism, especially a bacterium, virus, or fungus. 3d rendering.jpg
    News

    Monoclonal antibody programme targets mucormycosis

    2023-04-27T09:41:00Z

    Vitalex Biosciences has been awarded an SBIR Phase 2 grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health for VX-01, a monoclonal antibody (mAB) programme targeting the debilitating indication of the fungal disease, mucormycosis.